iohexol has been researched along with technetium tc 99m medronate in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Murphy, WD; Poulton, TB; Rauchenstein, JN | 1 |
| Claessens, RA; Corstens, FH; Lemmens, JA; Oyen, WJ; Slooff, TJ; van Horn, JR | 1 |
| Attard, G; Cook, G; de Bono, JS; de Souza, NM; Dearnaley, D; Messiou, C; Reid, AH | 1 |
3 other study(ies) available for iohexol and technetium tc 99m medronate
| Article | Year |
|---|---|
Diffuse liver and splenic activity with Tc-99m MDP associated with iohexol injection. A case report.
Topics: Aged; Bone and Bones; Colloids; Female; Humans; Iohexol; Liver; Pancreatitis; Radiography, Abdominal; Radionuclide Imaging; Spleen; Technetium Tc 99m Medronate; Tomography, X-Ray Computed | 1992 |
Nuclear arthrography: combined scintigraphic and radiographic procedure for diagnosis of total hip prosthesis loosening.
Topics: Cementation; Colloids; Evaluation Studies as Topic; Female; Hip Joint; Hip Prosthesis; Humans; Indium Radioisotopes; Iohexol; Male; Middle Aged; Predictive Value of Tests; Prosthesis Failure; Radiography; Radionuclide Imaging; Sensitivity and Specificity; Subtraction Technique; Technetium Tc 99m Medronate | 1996 |
The CT flare response of metastatic bone disease in prostate cancer.
Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Biomarkers, Tumor; Bone Neoplasms; Contrast Media; Diagnosis, Differential; Disease Progression; Humans; Iohexol; Male; Middle Aged; Osteoblasts; Prostate-Specific Antigen; Prostatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Statistics, Nonparametric; Technetium Tc 99m Medronate; Tomography, X-Ray Computed | 2011 |